Results 61 to 70 of about 175,090 (163)

MS Gr. class. c. 2 429

, 2023
P.Herc. 1003 II 429.
Oxyrhynchus Papyri (13045221)
core   +1 more source

Effects and mechanisms of a home-based action observation and motor imagery intervention on cognitive function and depression in spinal cord injury: a pilot randomized controlled trial protocol

Frontiers in Neurology
BackgroundCognitive impairment and depression frequently occur after spinal cord injury (SCI) and adversely affect functional independence and quality of life. There is a lack of research in addressing this important area in SCI rehabilitation/care.
Yule Hu, Yan Li, Ran Tao, Chun Liang Hsu, Ashley Craig, Ashley Craig, Chor Yin Lam, Turhan Kahraman, Angela Yee Man Leung   +8 more
doaj   +1 more source

[Veto of S. 429, R-429]

, 2008
This veto message from Governor Mark Sanford vetoes S. 429, R-429, a bill that provides individuals convicted of certain crimes with procedures to preserve DNA evidence and to challenge their conviction through the use of DNA evidence and requires all ...
Sanford, Mark (Marshall C.)
core  

MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2

, 2015
Background/Aims: MicroRNAs (miRNAs) play an essential role in the tumorigenesis of gastric carcinoma (GC). MiR-429 has been recently reported to inhibit GC growth, but the underlying mechanisms are not clear.
Jianfei Zhu, Ping Zhu, Jun Shi, Yuanyuan Gao, Qiuwei Zhu, Jingping Zhang   +5 more
core   +1 more source

Research progress of artificial intelligence in moyamoya disease

Frontiers in Neurology
Moyamoya disease (MMD), a chronic, progressive cerebrovascular disorder of unknown etiology, presents significant diagnostic and therapeutic challenges in clinical practice.
Huimin Huang, Huimin Huang, Ning Zheng, Lei Feng, Shuo Shao   +4 more
doaj   +1 more source

Rupicapra rupicapra 429

Skeleton of Rupicapra rupicapra ...
Lebrun, Brice
core   +1 more source

Switch from fingolimod to ozanimod for safety or intolerance reasons

Therapeutic Advances in Neurological Disorders
Introduction: Ozanimod is a new-generation sphingosine-1-phosphate (S1P) modulator, approved for the treatment of multiple sclerosis (MS), offering higher selectivity for S1P receptor 1 and 5 (SPR1-5), minimizing potential safety concerns related to S1P3
Elisabetta Signoriello, Giuseppe Romano, Matteo Foschi, Aurora Zanghì, Emanuele D’Amico, Roberta Fantozzi, Diego Centonze, Giacomo Lus   +7 more
doaj   +1 more source

Sphenopalatine ganglion stimulation for the treatment of trigeminal neuropathic pain

Frontiers in Neurology
IntroductionUnlike idiopathic trigeminal neuralgia, which can be treated with conventional neurosurgical methods such as microvascular decompression, radiofrequency rhizotomy of the Gasser ganglion, or stereotactic radiosurgery, trigeminal neuropathic ...
Paweł Sokal, Sara Kierońska-Siwak, Marcin Rusinek, Magdalena Jabłońska, Antoni Nehring, Oskar Puk, Damian Palus, Renata Jabłońska   +7 more
doaj   +1 more source

Chinese massage therapy (Tuina) inhibits motor neuron apoptosis in rats with sciatic nerve injury by regulating the cPLA2 and RhoA/ROCK2 signaling pathways

Frontiers in Neurology
ObjectiveTo investigate whether Tuina therapy alleviated inflammation and motor neuron apoptosis in sciatic nerve injury (SNI) rats by regulating cytosolic phospholipase A2 (cPLA2) and Ras homolog family member A/Rho-associated coiled-coil comprising ...
Jiawei Sun, Yingqi Zhang, Zhifeng Liu, Hanyu Zhang, Jiayue Liu, Yue Xu, Rentuya Na, Hongzheng Zhang, Jiawang Yan, Tianyuan Yu   +9 more
doaj   +1 more source

RAAPRAPPORT 429

, 2009
onderzoeksrappor
Oude Rengerink, J.A.M.
core   +1 more source